U.S. markets open in 6 hours 31 minutes

aTyr Pharma, Inc. (LIFE)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
12.01+1.79 (+17.51%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Bollinger Bands

Bollinger Bands

Previous Close10.22
Bid0.00 x 1300
Ask0.00 x 1000
Day's Range10.35 - 12.34
52 Week Range2.93 - 12.97
Avg. Volume4,977,063
Market Cap315.802M
Beta (5Y Monthly)2.00
PE Ratio (TTM)N/A
EPS (TTM)-2.30
Earnings DateNov 10, 2021 - Nov 15, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est19.40
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • aTyr Pharma, Inc.
    Analyst Report: United Therapeutics CorpUnited Therapeutics is a biotechnology company focused on the development and commercialization of therapeutic products for patients with cardiovascular conditions, cancer and infectious diseases. It has five approved products on the market and a strong new product pipeline. The company has roughly 950 employees and is a component of the S&P 400.
    Fair Value
    Economic Moat
    18 hours agoArgus Research
View more